BREAKING
Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 11 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 12 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 13 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 day ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 day ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 1 day ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 1 day ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 11 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 12 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 13 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 day ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 day ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 1 day ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 1 day ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago
ADVERTISEMENT
AlphaGraphs

EL Earnings: Highlights of Estee Lauder’s Q4 2023 financial report

Estee Lauder Companies Inc. (NYSE: EL) announced financial results for the fourth quarter of 2023, reporting modest revenue growth and lower adjusted earnings. First-quarter net sales edged up 1% annually to $3.61 billion. A decline in the core Skin Care segment was more than offset by growth in the other areas of the business. Adjusted […]

August 18, 2023 1 min read

Estee Lauder Companies Inc. (NYSE: EL) announced financial results for the fourth quarter of 2023, reporting modest revenue growth and lower adjusted earnings.

The Estée Lauder Companies Q4 2023 earnings infographic

First-quarter net sales edged up 1% annually to $3.61 billion. A decline in the core Skin Care segment was more than offset by growth in the other areas of the business.

Adjusted earnings, excluding one-off items, declined sharply to $0.07 per share in Q4 from $0.42 per share in the fourth quarter of 2022. On an unadjusted basis, the company reported a net loss of $33 million or $0.09 per share, compared to a profit of $52 million or $0.14 per share last year.

Fabrizio Freda, the company’s CEO, said, “We returned to organic sales growth in the fourth quarter, delivering our outlook. Momentum continued in the markets of EMEA and Latin America, and accelerated strongly in Asia/Pacific led by mainland China and Hong Kong SAR.”

ADVERTISEMENT

Prior Performance

ADVERTISEMENT